Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Should You Sell Your Moderna Stock Now?

TheMotleyFool

0 0

If you're a lucky Moderna (NASDAQ: MRNA) shareholder, congratulations. Now that the stock has reached a sky-high valuation, though, you're probably wondering if it's time to sell. After all, U.S. pharmaceutical giant Merck (NYSE: MRK) recently disclosed its sale of a stake in Moderna it had held since 2015.

Blindly following others in an attempt to time short-term stock price movements isn't a winning investment strategy. Still, it's probably a good time to consider what Moderna's underlying business needs to accomplish to meet the stock market's growing expectations.

Image source: Getty Images.

Source Fool.com

Like: 0

MRNA

Share